Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli

Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli

US Patent 10195262 · Granted Feb 5, 2019

Estimated economic value: $29,048,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for the manipulation of nucleic acids2025
Methods of host cell modification2025
Methods of host cell modification2025
Methods of producing bioconjugates of E. coli O-antigen polysaccharides, composi2025
Polysaccharide and uses thereof2025
Polysaccharide and uses thereof2025
Immunogenic composition2024
Methods and compositions for immune protection against extra-intestinal pathogen2024
Methods and compositions for immune protection against extra-intestinal pathogen2024
Process for the manipulation of nucleic acids2024
Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cel2024
Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cel2024